Adaptive resistance following single doses of gentamicin in a dynamic in vitro model
- 1 September 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (9) , 1951-1957
- https://doi.org/10.1128/aac.36.9.1951
Abstract
Adaptive resistance is a phenomenon recently described for Pseudomonas aeruginosa and other gram-negative bacilli following exposure to aminoglycoside antibiotics. It is a reversible form of resistance which develops within 1 to 2 h of initial exposure to an aminoglycoside and disappears several hours after removal of the antibiotic. We investigated adaptive resistance in P. aeruginosa ATCC 27853 following single doses of gentamicin by using a dynamic in vitro model which mimics in vivo pharmacokinetics. The initial peak gentamicin concentrations were 2.5, 8, and 25 mg/liter, and these were followed by an exponential decay in the concentration, with a half-life of 2.5 h. The degree of adaptive resistance was greater and the duration was longer with higher initial gentamicin concentrations. Maximal adaptive resistance occurred between 2 and 10 h following 8 mg/liter and between 2 and 16 h following 25 mg/liter. Full recovery of susceptibility occurred at approximately 36, 39, and 43 h following 2.5, 8, and 25 mg/liter, respectively, at which times the gentamicin concentrations were extremely low. Longer dosing intervals for aminoglycosides may improve efficacy by allowing time for adaptive resistance to resolve.Keywords
This publication has 36 references indexed in Scilit:
- Antimicrobial effects of lomefloxacin in vitroJournal of Antimicrobial Chemotherapy, 1991
- Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiencyJournal of Antimicrobial Chemotherapy, 1990
- Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Safety, Pharmacokinetics and Efficacy of Once-A-Daynetilmicin and Amikacin Versus Their Conventional Schedules in Patients Suffering from Pelvic Inflammatory DiseaseRenal Failure, 1990
- Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosaJournal of Medical Microbiology, 1989
- Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitisJournal of Antimicrobial Chemotherapy, 1988
- Adaptive alterations in the outer membrane of gram-negative bacteria during human infectionCanadian Journal of Microbiology, 1988
- A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycinThe Laryngoscope, 1987
- Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with GentamicinThe Journal of Infectious Diseases, 1971
- Intravenous Gentamicin Therapy for Infections in Patients with CancerThe Journal of Infectious Diseases, 1971